Overview

Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian Population

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary objective of this study was to evaluate the efficacy and the safety of sibutramine vs. placebo in combination with a hypocaloric diet on weight-loss in overweight and obese Malaysian subjects.
Phase:
Phase 3
Details
Lead Sponsor:
Abbott
Treatments:
Sibutramine